Niluja Thiruthaneeswaran

2PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 02, 2021
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.

Becky A S Bibby, Niluja Thiruthaneeswaran, Lingjian Yang

Pageof 1